Form 4: RxSight Director Juliet Tammenoms Bakker Reports Acquisition of 2,554 Shares of Common Stock

Director Juliet Tammenoms Bakker reports acquisition of 2,554 shares of RxSight, Inc. common stock and ownership of 37,394 direct shares and 1,548 indirect shares.

Summary

• On June 6, 2024, Juliet Tammenoms Bakker, a director of RxSight, Inc. (RXST), acquired 2,554 shares of common stock.
• These shares were obtained through the grant of restricted stock units (RSUs).
• Following the transaction, Ms. Bakker directly owns 37,394 shares of RxSight common stock.
• She also indirectly owns 1,548 shares through a trust where she serves as the Investment Trustee.
• The RSUs will vest on the earlier of June 6, 2025, or the day before the next annual meeting of stockholders, contingent upon her continued service as an Outside Director.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by a director is generally a good sign, but it's a routine transaction related to compensation.

Positives

• The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The vesting of the RSUs is contingent upon the director's continued service, aligning her interests with the long-term performance of the company.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. Monitoring such filings can provide insights into management's sentiment and alignment with shareholder interests.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it signals confidence from a member of the board of directors.

Key Dates